Abbott Labs

Abbott to study blood thinners after treatment with Xience drug-eluting stent
Abbott to study blood thinners after treatment with Xience drug-eluting stent
Drug Delivery Business News
Abbott Labs
blood thinners
Xience stents
devices
Flag link:
Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment
Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment
Drug Delivery Business News
Abbott Labs
devices
diabetes
Miles White
Bigfoot Biomedical
Flag link:
Abbott Zeros In On A 2-Year High After Topping Q2 Sales, Profits
Abbott Zeros In On A 2-Year High After Topping Q2 Sales, Profits
Investors Business Daily
Abbott Labs
earnings
Flag link:
Abbott launches tender offer for Alere in $5.3B merger
Abbott launches tender offer for Alere in $5.3B merger
Drug Delivery Business News
Abbott Labs
Alere
diagnostics
devices
M&A
Flag link:
Bigfoot Biomedical taps Abbott to collaborate on automated insulin delivery tech
Bigfoot Biomedical taps Abbott to collaborate on automated insulin delivery tech
Mass Device
Abbott Labs
Bigfoot Biomedical
devices
insulin delivery
diabetes
Flag link:
Medtech Mergers Surge Again
Medtech Mergers Surge Again
Seeking Alpha
devices
M&A
Abbott Labs
Cutera
St. Jude Medical
Allergan
Syneron
JNJ
Flag link:
Alere shareholders approve amended $5.3B Abbott merger
Alere shareholders approve amended $5.3B Abbott merger
Mass Device
devices
M&A
Abbott Labs
Alere
shareholders
Flag link:
Medtech M&A: The 10 biggest deals so far in 2017
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
devices
M&A
Abbott Labs
St. Jude Medical
Edwards Lifesciences
Valtech Cardio
Hologic
Cynosure
JNJ
Teleflex
Vascular Soltions
Cardinal Health
Medtronic
Becton Dickinson
CR Bard
Boston Scientific
Symetis
Integra LifeSciences
Codman Neuro
Stryker
Novadaq
Flag link:
Abbott Laboratories at 52-Week High on Product Line, Buyouts
Abbott Laboratories at 52-Week High on Product Line, Buyouts
Yahoo/Zacks.com
Abbott Labs
devices
St. Jude Medical
Flag link:
Alere, set to be acquired by Abbott, dealt setback in Medicare case
Alere, set to be acquired by Abbott, dealt setback in Medicare case
Bizjournals.com
Alere
Abbott Labs
Medicare
M&A
Flag link:
Abbott CEO White optimistic on Alere buy
Abbott CEO White optimistic on Alere buy
Mass Device
Abbott Labs
Pharma CEOs
Alere
M&A
devices
Miles White
Flag link:
Abbott CEO Upbeat Despite Ongoing Merger Headaches
Abbott CEO Upbeat Despite Ongoing Merger Headaches
TheStreet.com
Abbott Labs
Pharma CEOs
M&A
Miles White
Alere
St. Jude Medical
Flag link:
Abbott's profit rises 33 percent after St. Jude Medical deal
Abbott's profit rises 33 percent after St. Jude Medical deal
Yahoo/AP
Abbott Labs
devices
St. Jude Medical
earnings
M&A
Flag link:
Abbott Laboratories’ 1Q17 Earnings: What to Expect
Abbott Laboratories’ 1Q17 Earnings: What to Expect
Market Realist
Abbott Labs
earnings
Flag link:
Abbott agrees to lower, $5.3B price for Alere
Abbott agrees to lower, $5.3B price for Alere
Mass Device
Abbott Labs
Alere
devices
M&A
Flag link:
Abbott's St. Jude Medical Hit With FDA Warning Letter
Abbott's St. Jude Medical Hit With FDA Warning Letter
Yahoo/GuruFocus
Abbott Labs
St. Jude Medical
FDA
warning
devices
cybersecurity
Flag link:
These big medtech names performed the best in early 2017
These big medtech names performed the best in early 2017
Mass Device
devices
DexCom
Masimo
Intuitive Surgical
Abbott Labs
Boston Scientific
Insulet
Flag link:
Abbott divests 60% of its stake in Mylan
Abbott divests 60% of its stake in Mylan
Mass Device
Abbott Labs
Mylan Labs
generics
Flag link:
Abbott Poised to Perform Well - As Long As it Closes Alere Litigation
Abbott Poised to Perform Well - As Long As it Closes Alere Litigation
TheStreet.com
Abbott Labs
Alere
devices
M&A
Flag link:
Abbott denies reports it will bail on India’s high-end stent market
Abbott denies reports it will bail on India’s high-end stent market
Mass Device
Abbott Labs
India
coronary stents
devices
Flag link: